Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.62 -0.88%   SPY: 165.93 -0.74%
Profile Portfolio  


  Track this Pro and follow their portfolio moves with tickerspy™ alerts  

Abingworth

  Performance       Similar Pro Portfolios       Community  
 
Today:
Week:
1-month:
All-time:
-1.6%
-1.1%
+4.4%
+11.3%
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
-0.9%
-0.9%
-1.9%
-20.7%
 

Data since: Jan-1-2011
Current Portfolio: Q1 2013


     
Jeffrey R. Jay -1.5%
NEA Management ... -1.1%
Baker Bros. Adv... -1.0%
     
35 members Tracking
Share this Pro on Facebook
Share this Pro on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
   
 
 

 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Q1 2013 View as: Alerts Holdings Detail
 ALNY $27.84 -0.19 -0.68% 456,401 106% $1.7B - 185% -3% +18.3% $12.5M | 514.1K shares - decrease of 600.0K shares
 ALXA $4.67 -0.01 -0.21% 408,779 63% $73.9M - 83% -30% +6.1% $1.3M | 286.9K shares - decrease of 1 shares
 AMRN $6.89 -0.09 -1.29% 3,728,698 97% $1.0B - 9% -57% -6.4% $59.9M | 8.1M shares - No Change
 ANTH $0.60 0.00 0.00% 665,168 103% $89.3M - 22% -81% -8.4% $2.3M | 3.5M shares - No Change
 ASTX $5.20 -0.43 -7.64% 1,297,220 82% $526.8M - 225% -25% +13.8% $11.4M | 2.6M shares - decrease of 1.9M shares
 CLVS $33.29 -1.90 -5.40% 237,355 126% $922.6M - 197% -17% +21.7% $26.9M | 938.7K shares - decrease of 364.9K shares
 CRTX $8.34 -0.20 -2.34% 78,083 89% $225.6M - 169% -9% +17.1% $599.1K | 84.7K shares - No Change
 EXEL $4.58 -0.03 -0.65% 1,293,199 79% $847.2M - 9% -34% +0.4% $1.9M | 415.0K shares - No Change
 HPTX $20.37 -0.43 -2.07% 91,842 109% $416.2M - 105% -23% -18.5% $1.6M | 62.5K shares - New Holding
 INCY $22.32 +0.06 +0.27% 1,235,415 118% $3.0B - 45% -15% -3.0% $6.8M | 290.0K shares - decrease of 290.5K shares
 ISIS $20.39 -0.42 -2.02% 1,415,123 79% $2.1B - 170% -11% +19.8% $4.5M | 267.6K shares - No Change
 OGXI $10.17 -0.28 -2.68% 74,809 94% $153.3M - 11% -32% -5.8% $6.8M | 603.7K shares - No Change
 SUPN $6.60 +0.30 +4.76% 3,643,030 557% $194.6M - 53% -60% +23.6% $20.2M | 3.6M shares - No Change
 ZGNX $1.51 -0.01 -0.66% 414,635 63% $153.2M - 36% -54% -15.2% $4.2M | 2.3M shares - No Change
 ZLCS $0.60 -0.00 -0.48% 409,943 58% $76.3M - 39% -63% -9.5% $576.3K | 864.0K shares - No Change
Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Discuss Abingworth's portfolio
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Amarin Announces Notification of Patent Allowance for U.S. Application 13/417,899 Related to Combination Product of Vascepa(R) and Statin Therapy
AMRN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 22, 06:13AM from (globenewswire.com)
BEDMINSTER, N.J., and DUBLIN, Ireland, May 22, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Teva Bets on Reformulating Old Drugs as Investors Say 'Show Me'
BMY  FRX  LLY  JNJ  BIIB  ALXA  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 21, 07:01AM from (www.bloomberg.com)
Teva Pharmaceutical Industries Ltd. (TEVA), which just two years ago was analysts’ highest-rated stock among the world’s  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Supernus to Present at Two Investor Conferences
SUPN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 20, 04:43PM from (globenewswire.com)
ROCKVILLE, Md., May 20, 2013 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix and Battelle to Present Positive, New Data Demonstrating Value of Needle-Free Injection for Biologics
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 20, 07:43AM from (globenewswire.com)
SAN DIEGO and COLUMBUS, Ohio, May 20, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) and Battelle Memorial Institute  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alexza Reports 2013 First Quarter Financial Results
ALXA  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 14, 04:05PM

MOUNTAIN VIEW, Calif., May 14, 2013 /PRNewswire/ -- Alexza  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Astex Pharmaceuticals to Present at UBS Global Healthcare Conference
ASTX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 06:13AM from (globenewswire.com)
DUBLIN, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
ANTH  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 13, 05:23PM

HAYWARD, Calif., May 13, 2013 /PRNewswire/ -- Anthera  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Supernus Pharmaceuticals Reports First Quarter 2013 Financial Results
SUPN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 13, 04:13PM from (globenewswire.com)
ROCKVILLE, Md., May 13, 2013 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and Upcoming Deadline -- INCY
INCY  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 03:43PM from (globenewswire.com)
NEW YORK, May 10, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Adasuve Deal Is Very Good For Alexza, But What About Teva?
BMY  LLY  TEVA  VRX  ALXA  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 09, 04:45PM from (www.investopedia.com)
Teva's partnership with Alexza looks like an expensive gamble.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Photo Release -- Amarin Reports First Quarter 2013 Financial Results and Provides Update on Operations
AMRN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 09, 04:13PM from (globenewswire.com)
BEDMINSTER, N.J., and DUBLIN, Ireland, May 9, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Another Negative Fish Oil Study Adds To Amarin's Marketing Challenges
AMRN  SNY  GSK  LPDX  OMTH  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 09, 12:30PM from (www.investopedia.com)
More questions about the real efficacy of fish oil is bad news for Amarin.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S.
TEVA  ALXA  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 08, 08:30AM from (www.businesswire.com)
Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: TEVA), and Alexza Pharmaceuticals,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call
CRTX  
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 08, 08:00AM from (www2.marketwire.com)
Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Exelixis Announces First Quarter 2013 Financial Results
EXEL  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 04:15PM from (www.businesswire.com)
Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the quarter ended March 31, 2013. Q1 2013 Highlights and  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Closing Bell for Tuesday on Wall Street: Share Prices Push Indexes to All-time Highs
WEN  MRO  CKP  KGC  EA  APC  FTEK  INCY  VVUS  FOSL  ENB  VNO  ANF  CRZO  PAA  JCP  FSLR  ANR  SD  AWK  DTV  AOL  DMD  Z  SN  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 07, 04:05PM from (247wallst.com)
U.S. equity markets opened higher this morning following an unexpected 0.25% cut in Australia’s key interest rate to a  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Isis Reports Financial Results and Highlights for First Quarter 2013
ISIS  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 07, 04:05PM

CARLSBAD, Calif., May 7, 2013 /PRNewswire/ -- Isis Pharmaceuticals,  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Top Wall Street Analyst Downgrades: AIG, Coach, J.C. Penney and More
AIG  TIF  TJX  INCY  COH  JCP  TMUS  ANR  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 07, 08:35AM from (247wallst.com)
Investors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors often do not  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Clovis Oncology Announces First Quarter 2013 Operating Results
CLVS  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 07:00AM from (www.businesswire.com)
Clovis Oncology, Inc. (NASDAQ:CLVS) today reported financial results for its first quarter ended March 31, 2013, and provided  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 48



Close [X]  
Post a description about this portfolio.
(150 character limit)

Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
The Recent Tickers portfolio saves the tickers you've recently viewed on the site.